58
Participants
Start Date
April 5, 2012
Primary Completion Date
January 31, 2014
Study Completion Date
January 31, 2014
Evolocumab
Administered by subcutaneous injection
Placebo
Administered by subcutaneous injection
Research Site, Brussels
Research Site, Johannesburg
Research Site, La Louvière
Research Site, Observatory
Research Site, Christchurch
Research Site, New York
Research Site, Córdoba
Research Site, Dijon
Research Site, Lugo
Research Site, Madrid
Research Site, Cincinnati
Research Site, Pisa
Research Site, Paris
Research Site, London
Research Site, Chicoutimi
Research Site, Brno
Research Site, Hradec Králové
Research Site, Uherské Hradiště
Research Site, New Territories
Research Site, Beirut
Research Site, Amsterdam
Lead Sponsor
Amgen
INDUSTRY